<PubmedArticle>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">27612989</PMID>
<DateCompleted>
<Year>2017</Year>
<Month>07</Month>
<Day>07</Day>
</DateCompleted>
<DateRevised>
<Year>2019</Year>
<Month>07</Month>
<Day>09</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1592-8721</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>102</Volume>
<Issue>2</Issue>
<PubDate>
<Year>2017</Year>
<Month>02</Month>
</PubDate>
</JournalIssue>
<Title>Haematologica</Title>
<ISOAbbreviation>Haematologica</ISOAbbreviation>
</Journal>
<ArticleTitle>Distinct global binding patterns of the Wilms tumor gene 1 (WT1) -KTS and +KTS isoforms in leukemic cells.</ArticleTitle>
<Pagination>
<MedlinePgn>336-345</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.3324/haematol.2016.149815</ELocationID>
<Abstract>
<AbstractText>The zinc finger transcription factor Wilms tumor gene 1 (WT1) acts as an oncogene in acute myeloid leukemia. A naturally occurring alternative splice event between zinc fingers three and four, removing or retaining three amino acids (±KTS), is believed to change the DNA binding affinity of WT1, although there are conflicting data regarding the binding affinity and motifs of the different isoforms. Increased expression of the WT1 -KTS isoform at the expense of the WT1 +KTS isoform is associated with poor prognosis in acute myeloid leukemia. We determined the genome-wide binding pattern of WT1 -KTS and WT1 +KTS in leukemic K562 cells by chromatin immunoprecipitation and deep sequencing. We discovered that the WT1 -KTS isoform predominantly binds close to transcription start sites and to enhancers, in a similar fashion to other transcription factors, whereas WT1 +KTS binding is enriched within gene bodies. We observed a significant overlap between WT1 -KTS and WT1 +KTS target genes, despite the binding sites being distinct. Motif discovery revealed distinct binding motifs for the isoforms, some of which have been previously reported as WT1 binding sites. Additional analyses showed that both WT1 -KTS and WT1 +KTS target genes are more likely to be transcribed than non-targets, and are involved in cell proliferation, cell death, and development. Our study provides evidence that WT1 -KTS and WT1 +KTS share target genes yet still bind distinct locations, indicating isoform-specific regulation in transcription of genes related to cell proliferation and differentiation, consistent with the involvement of WT1 in acute myeloid leukemia.</AbstractText>
<CopyrightInformation>Copyright© Ferrata Storti Foundation.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ullmark</LastName>
<ForeName>Tove</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Division of Hematology and Transfusion Medicine, Department of Laboratory Medicine, Lund University, Huddinge, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Järvstråt</LastName>
<ForeName>Linnea</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Division of Hematology and Transfusion Medicine, Department of Laboratory Medicine, Lund University, Huddinge, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sandén</LastName>
<ForeName>Carl</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Huddinge, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Montano</LastName>
<ForeName>Giorgia</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Division of Hematology and Transfusion Medicine, Department of Laboratory Medicine, Lund University, Huddinge, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jernmark-Nilsson</LastName>
<ForeName>Helena</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Division of Hematology and Transfusion Medicine, Department of Laboratory Medicine, Lund University, Huddinge, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lilljebjörn</LastName>
<ForeName>Henrik</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Huddinge, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lennartsson</LastName>
<ForeName>Andreas</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fioretos</LastName>
<ForeName>Thoas</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Huddinge, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Drott</LastName>
<ForeName>Kristina</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Division of Hematology and Transfusion Medicine, Department of Laboratory Medicine, Lund University, Huddinge, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Vidovic</LastName>
<ForeName>Karina</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Division of Hematology and Transfusion Medicine, Department of Laboratory Medicine, Lund University, Huddinge, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nilsson</LastName>
<ForeName>Björn</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Division of Hematology and Transfusion Medicine, Department of Laboratory Medicine, Lund University, Huddinge, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gullberg</LastName>
<ForeName>Urban</ForeName>
<Initials>U</Initials>
<AffiliationInfo>
<Affiliation>Division of Hematology and Transfusion Medicine, Department of Laboratory Medicine, Lund University, Huddinge, Sweden urban.gullberg@med.lu.se.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2016</Year>
<Month>09</Month>
<Day>09</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Italy</Country>
<MedlineTA>Haematologica</MedlineTA>
<NlmUniqueID>0417435</NlmUniqueID>
<ISSNLinking>0390-6078</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014157">Transcription Factors</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D025721">WT1 Proteins</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D017398">Alternative Splicing</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001665">Binding Sites</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D047369">Chromatin Immunoprecipitation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D015973">Gene Expression Regulation, Leukemic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D059014">High-Throughput Nucleotide Sequencing</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007938">Leukemia</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D059372">Nucleotide Motifs</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011485">Protein Binding</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014157">Transcription Factors</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D024363">Transcription Initiation Site</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D025721">WT1 Proteins</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2016</Year>
<Month>05</Month>
<Day>20</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2016</Year>
<Month>09</Month>
<Day>05</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2016</Year>
<Month>9</Month>
<Day>11</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2017</Year>
<Month>7</Month>
<Day>8</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2016</Year>
<Month>9</Month>
<Day>11</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">27612989</ArticleId>
<ArticleId IdType="pii">haematol.2016.149815</ArticleId>
<ArticleId IdType="doi">10.3324/haematol.2016.149815</ArticleId>
<ArticleId IdType="pmc">PMC5286941</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Br J Cancer. 2010 Oct 12;103(8):1255-62</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20842112</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Endocrinol. 2014 Aug;10(8):476-87</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24913517</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer. 2009 Aug 15;115(16):3719-27</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19536888</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Am Soc Nephrol. 2015 Sep;26(9):2118-28</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25556170</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Am Soc Nephrol. 2015 Sep;26(9):2097-104</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25636411</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2014 Mar 27;507(7493):462-70</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24670764</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Expert Opin Investig Drugs. 2014 Mar;23(3):417-26</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24521058</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Leukemia. 2012 Sep;26(9):2086-95</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22430637</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nucleic Acids Res. 2000 Jan 1;28(1):316-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10592259</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2000 Oct 24;97(22):11932-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11050227</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 1990 Jun 29;61(7):1257-69</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2163761</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2014 Mar 27;507(7493):455-61</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24670763</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2010 Jan 8;285(2):1393-403</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19887448</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 1994 Feb 25;269(8):6198-206</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8119964</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Genome Med. 2014 Dec 01;6(12):84</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25452766</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Blood. 2009 Jun 4;113(23):5951-60</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19171881</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2012 Sep 6;489(7414):57-74</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22955616</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Genome Res. 2012 Sep;22(9):1813-31</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22955991</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 1993 Oct 1;90(19):8896-900</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8415628</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Sci Rep. 2015 Mar 09;5:8924</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25748047</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Cell Biol. 1995 Mar;15(3):1489-98</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7862142</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Oncotarget. 2015 Sep 29;6(29):28223-37</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26320177</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Oncogene. 2004 Sep 9;23(41):6933-41</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15286719</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Hum Mol Genet. 2013 Jan 1;22(1):74-83</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23042785</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Hum Mol Genet. 2013 May 1;22(9):1771-82</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23362234</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Hum Genet. 2013 Jul;58(7):439-45</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23739122</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Blood. 1997 Aug 1;90(3):1217-25</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9242555</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Leukemia. 2013 Nov;27(11):2157-64</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23584566</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Development. 2010 Apr;137(7):1189-203</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20215353</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Br J Cancer. 1998;77(2):253-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9460996</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2012 Sep 21;287(39):32875-80</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22898820</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Leukemia. 2010 May;24(5):992-1000</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20237505</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Leukemia. 2007 May;21(5):868-76</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17361230</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Commun. 2014 Jul 17;5:4444</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25031030</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Development. 1995 Mar;121(3):867-75</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7720589</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Mol Biol. 2008 Apr 29;9:44</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18445271</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Oncol. 2008 Nov 20;26(33):5429-35</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18591546</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 1990 Nov 30;250(4985):1259-62</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2244209</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur J Haematol. 2013 Nov;91(5):411-22</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23826993</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Blood Cells Mol Dis. 2012 Jun 15;49(1):41-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22555024</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Cancer. 2014 Sep 12;13:215</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25216995</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Blood. 2006 Apr 15;107(8):3303-12</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16380455</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Trends Genet. 2012 Oct;28(10):515-24</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22658804</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Hematol Oncol. 2010 Mar;28(1):13-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20013787</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Physiol Genomics. 2001 Dec 21;7(2):187-200</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11773605</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 1992 Jul 10;257(5067):235-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1321494</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Protoc. 2009;4(4):506-17</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19325547</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 1992 Nov 15;89(22):10984-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1332065</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Mol Cell Biol. 2015 Jul;16(7):431-42</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26081607</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</PubmedArticle>